Profile
BCDA VRTX REGN SGEN ALNY ARGX
Company Name BioCardia, Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. Alnylam Pharmaceuticals, Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $11.13M $116.96B $55.30B $43.15B $41.50B $33.66B
Employees 0.02K 6.10K 15.16K 3.26K 2.23K 1.60K
CEO Peter A. Altman Dr. Reshma Kewalramani FASN, M.D. Leonard S. Schleifer David R. Epstein Yvonne L. Greenstreet Mr. Timothy Van Hauwermeiren EMBA, M.Sc.
Ratings
BCDA VRTX REGN SGEN ALNY ARGX
Quant Rating Score 2 2 4 3 1 1
Quant Rating Sell Sell Buy Neutral Strong Sell Strong Sell
Trading
BCDA VRTX REGN SGEN ALNY ARGX
Last Close $2 $452.16 $534.91 $228.74 $322.06 $542.47
High 52 $4.02 $516.74 $1201.76 $228.74 $326.09 $671.75
Low 52 $1.75 $396.64 $482.92 $228.74 $224.58 $435.29
Price vs. 52 Week High -50.25 % -12.5 % -55.49 % 0 % -1.24 % -19.25 %
Price vs. 52 Week Low 14.29 % 14 % 10.77 % 0 % 43.41 % 24.62 %
Total Return
BCDA VRTX REGN SGEN ALNY ARGX
1 Month Return -11.5 % 1.51 % 9.03 % 0 % 5.22 % -7.21 %
3 Month Return -11.89 % -6.48 % -14.5 % 0 % 20.7 % -6.84 %
6 Month Return -13.42 % 11.07 % -25.52 % 0 % 37.47 % -12.69 %
9 Month Return -27.54 % -2.16 % -48.58 % 0 % 18.6 % -1.37 %
YTD Return -8.26 % 12.28 % -24.91 % 0 % 36.87 % -11.79 %
1 Year Return -31.97 % -4.56 % -48.8 % 0 % 30.07 % 24.57 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
BCDA VRTX REGN SGEN ALNY ARGX
Dividend Yield Percentage (TTM) - - 0.34 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -1352.33 % -3.53 % 3.85 % -5.87 % -1.49 % -44.32 %
Dividend Per Share (TTM) - - 1.76 % - - -
Payout Ratio (TTM) - - 2.08 % - - -
Growth
BCDA VRTX REGN SGEN ALNY ARGX
Asset Growth 24.67 % -0.87 % 36.55 %
Gross Profit Growth 100.8 % 10.25 % 77.08 %
Revenue Growth -87.84 % 11.66 % 78.6 %
Revenue 3 Year -97.65 % 45.6 % 275.84 %
Revenue 5 Year -98.88 % 163.93 % 1701.04 %
Revenue 10 Year -99.94 % 1632.15 % 5950.81 %
EBIT Growth 31.29 % -93.69 % 128.87 %
Net Income Growth 31.33 % -114.8 % 382.34 %
Net Income 3 Yeari Growth Per Share 74.12 % -122.89 % 274.39 %
Net Income 5 Yeari Growth Per Share 92.65 % -145.38 % 396.61 %
Net Income 10 Yeari Growth Per Share -114.13 % 33.84 % 938.02 %
Operating Income Growth 31.29 % -106.08 % 94.91 %
Operating Cash Flow Growth (CFG) 19.53 % -113.93 % 80.31 %
Operating 3 Year CFG 68.17 % -118.65 % 88.36 %
Operating 5 Year CFG 88.35 % -131.3 % -135.21 %
Operating 10 Year CFG -115.6 % 12.43 % -64 %
EPS Growth 64.59 % -114.8 % 369.77 %
EPS Diluted Growth 99.96 % -114.97 % 347.67 %
Book Value Per Share 126.87 % -6.59 % 28.16 %
Share Holder 3 Year Equity Growth Per Share -96.68 % 62.6 % 85.14 %
Share Holder 5 Year Equity Growth Per Share -95.16 % 168.85 % 200.53 %
Share Holder 10 Year Equity Growth Per Share -99.97 % 1265.7 % 1039.11 %
Dividend Per Share Growth - - -
Dividend 3 Year Growth Per Share - - -
Dividend 5 Year Growth Per Share - - -
Dividend 10 Year Growth Per Share - - -
Debt Growth -27.68 % 116.42 % 95.27 %
Free Cash Flow Growth 19.57 % -124.1 % 67.46 %
Updated On 31 Dec 2024 31 Dec 2024 31 Dec 2024
Profitability
BCDA VRTX REGN SGEN ALNY ARGX
Gross Profit Margin TTM 387.27 % 86.03 % 84.94 % 79.1 % 86.01 % 46.33 %
Return on Assets TTM -387.4 % -4.32 % 11.98 % -16.61 % -6.4 % 13.45 %
Return on Equity TTM -30792.66 % -6.25 % 14.77 % -20.8 % -509.33 % 16.83 %
Return on Capital Employed TTM 536.14 % -3.89 % 11.35 % -21.46 % -3.68 % -0.5 %
Net Income Per EBT TTM 100 % 329.41 % 90.27 % 101.33 % 75.89 % 25990.14 %
EBT Per Ebit TTM 146.54 % 40.44 % 129.3 % 98.26 % 308.03 % -11.64 %
EBIT Per Revenue TTM 10410.91 % -6.69 % 27.37 % -31.24 % -4.91 % -1.24 %
Cash Flow To Debt Ratio TTM -954.59 % -59.44 % 146.15 % -1043.73 % -3.47 % -201.37 %
Receivables Turnover TTM - 6.15 2.53 3.91 5.62 2.36
Payables Turnover TTM 0.13 3.49 3.01 1.97 3.37 2.39
Inventory Turnover TTM - 1.14 0.66 0.96 5.01 2.93
Fixed Asset Turnover TTM -6.69 % 421.34 % 300.07 % 665.41 % 337.41 % 5106.8 %
Asset Turnover TTM -2.54 % 48.51 % 37.52 % 53.41 % 55.72 % 35.83 %
Operating Cash Flow Per Share TTM -1.75 -3.82 37.05 -2.46 -0.35 -1.07
Free Cash Flow Per Share TTM -1.75 -4.9 28.3 -2.88 -0.58 -1.09
Cash Per Share TTM 20.47 % 2413.86 % 7825.12 % 939.52 % 2024.29 % 4688.94 %
Operating Cash Flow Sales Ratio TTM 14752.73 % -8.83 % 28.06 % -23.12 % -1.92 % -3.54 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.07 % 128.33 % 76.4 % 117.04 % 167.11 % 102.26 %
Cash Flow Coverage Ratios TTM -954.59 % -59.44 % 146.15 % -1043.73 % -3.47 % -201.37 %
Price To Free Cash Flows Ratio TTM -1.37 -92.97 18.31 -81.26 -550.45 -433.65
Price To Operating Cash Flows Ratio TTM -1.23 -119.36 14.06 -93.1 -914.84 -515.25
Price Cash Flow Ratio TTM -1.23 -119.36 14.06 -93.1 -914.84 -515.25
Income Statement (TTM)
BCDA VRTX REGN SGEN ALNY ARGX
Revenue $0B $11.02B $14.2B $1.96B $2.25B $2.19B
Gross Profit $-0B $9.49B $12.23B $1.55B $1.92B $1.96B
Gross Profit Ratio -7463.79% 86.11% 86.13% 79.1% 85.62% 89.62%
EBITDA $-0.01B $0.49B $5.32B $-0.62B $-0.18B $0.11B
Net Income $-0.01B $-0.54B $4.41B $-0.61B $-0.28B $0.83B
EPS Diluted -2.9 -2.08 38.34 -3.3 -2.16 12.78
Balance Sheet (MRQ)
BCDA VRTX REGN SGEN ALNY ARGX
Long Term Debt $0B $1.66B $1.98B $0.04B $0B $0.03B
Total Liabilities $0B $6.12B $8.41B $0.87B $4.17B $0.7B
Total Equity $0B $16.41B $29.35B $2.8B $0.07B $5.5B
Total Investments $0B $6.65B $15.42B $1.42B $1.73B $1.93B
Total Debt $0B $1.75B $2.7B $0.04B $1.3B $0.04B
Total Assets $0B $22.53B $37.76B $3.67B $4.3B $6.2B
Cash Flow Statement (TTM)
BCDA VRTX REGN SGEN ALNY ARGX
Net Income $-0.01B $-0.54B $4.41B $-0.61B $-0.28B $-0.02B
Inventory $0B $-0.52B $-0.62B $-0.23B $0.01B $-0.09B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.01B $-0.49B $4.42B $-0.45B $-0.01B $-0.08B
Capital Expenditure $-0B $-0.3B $-0.76B $-0.08B $-0.03B $-0.07B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 38.99
AARD Aardvark Therapeutics, Inc. Common Stock 13.56
ABCL AbCellera Biologics Inc. 3.49
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.57
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.11
ABPWW 0.0222
ABSI Absci Corporation 2.59
ABUS Arbutus Biopharma Corporation 3.18
ABVC ABVC BioPharma, Inc. 2.42
ABVX Abivax SA American Depositary Shares 7.66
ACAD ACADIA Pharmaceuticals Inc. 21.36
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.6111
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 2.22
ACIU AC Immune SA 1.98
ETFs With Exposure to BCDA
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 303.93
VXF Vanguard Extended Market Index Fund 0 193.58
IWC iShares Micro-Cap ETF 0.001 128.74
VTSAX Vanguard Total Stock Market Index Fund 0 147.93
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 146.74
VITSX Vanguard Total Stock Market Index Fund 0 147.95
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 146.75
VEMPX Vanguard Extended Market Index InstlPlus 0 362.12
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 277.54
Unlock